1.33
price up icon0.76%   0.01
after-market Handel nachbörslich: 1.33
loading
Schlusskurs vom Vortag:
$1.32
Offen:
$1.33
24-Stunden-Volumen:
2.56M
Relative Volume:
0.78
Marktkapitalisierung:
$1.09B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-7.00
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
+3.10%
1M Leistung:
-2.21%
6M Leistung:
-9.52%
1J Leistung:
+8.13%
1-Tages-Spanne:
Value
$1.31
$1.36
1-Wochen-Bereich:
Value
$1.26
$1.36
52-Wochen-Spanne:
Value
$1.19
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
Firmenname
Opko Health Inc
Name
Telefon
305-575-4181
Name
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Name
Mitarbeiter
2,997
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
OPK's Discussions on Twitter

Vergleichen Sie OPK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
OPK
Opko Health Inc
1.33 1.09B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.47 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.10 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.65 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.45 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.61 27.64B 15.50B 1.33B 2.16B 7.34

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-25 Eingeleitet JP Morgan Neutral
2023-06-29 Hochstufung Barrington Research Mkt Perform → Outperform
2022-12-15 Eingeleitet H.C. Wainwright Buy
2022-01-24 Herabstufung Barrington Research Outperform → Mkt Perform
2021-06-21 Eingeleitet Ladenburg Thalmann Buy
2019-11-25 Eingeleitet Piper Jaffray Overweight
2018-03-02 Herabstufung JP Morgan Neutral → Underweight
2017-09-14 Herabstufung JP Morgan Overweight → Neutral
2016-06-21 Bestätigt Standpoint Research Buy
2016-06-03 Eingeleitet Standpoint Research Buy
2016-03-31 Bestätigt Barrington Research Outperform
2015-10-16 Eingeleitet JP Morgan Overweight
2015-09-11 Herabstufung Jefferies Buy → Hold
2015-03-03 Herabstufung Oppenheimer Outperform → Perform
2014-05-12 Bestätigt Oppenheimer Outperform
2014-03-14 Eingeleitet Oppenheimer Outperform
2013-11-13 Bestätigt Ladenburg Thalmann Buy
2013-05-30 Bestätigt Ladenburg Thalmann Buy
2012-10-22 Eingeleitet Barrington Research Outperform
2011-12-01 Bestätigt Ladenburg Thalmann Buy
2011-07-14 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Opko Health Inc Aktie (OPK) Neueste Nachrichten

pulisher
Jun 18, 2025

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Quote - OPKO Health, Inc.

Jun 13, 2025
pulisher
Jun 13, 2025

Bone Cancer Drugs Market Set to Witness Significant Growth - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board - StreetInsider

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Cuts Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Two Sigma Investments LP - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Peptide Therapeutics Market Growth Set to Surge Significantly - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Bone Cancer Drugs Market in 2025-2032 Detailed Study Analysis - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Sells 195,118 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 8,064 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Q2 EPS Estimates for OPKO Health Reduced by Zacks Research - MarketBeat

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Boosts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Grows Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 30, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Opko Health Grants Stock Options and Bonuses - TipRanks

May 29, 2025
pulisher
May 28, 2025

OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SA Asks: What are the best oncology stocks right now? - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Millennium Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 27, 2025
pulisher
May 26, 2025

Down Syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 24, 2025

What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st

May 24, 2025
pulisher
May 22, 2025

Hyperparathyroidism Treatment Market: Effective Treatment - openPR.com

May 22, 2025
pulisher
May 22, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Lazard Asset Management LLC - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Opko Health at BioConnect: Strategic Shifts and Financial Insights By Investing.com - Investing.com India

May 20, 2025
pulisher
May 18, 2025

Opko Completes Prolor Deal - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Grows Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 18, 2025
pulisher
May 17, 2025

Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance

May 17, 2025
pulisher
May 15, 2025

Esoteric Testing Market Set to Witness Significant Growth - openPR.com

May 15, 2025
pulisher
May 15, 2025

OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Lowers Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 14, 2025

Finanzdaten der Opko Health Inc-Aktie (OPK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Opko Health Inc-Aktie (OPK) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 08 '25
Buy
1.48
125,000
184,650
213,876,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 01 '25
Buy
1.65
100,000
164,850
213,751,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 28 '25
Buy
1.70
150,000
254,385
213,651,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 17 '25
Buy
1.74
200,000
347,820
213,501,448
FROST PHILLIP MD ET AL
CEO & Chairman
Feb 28 '25
Buy
1.71
67,434
115,312
213,301,448
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 28 '25
Buy
1.47
47,537
70,060
213,234,014
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 17 '25
Buy
1.47
150,000
220,425
213,186,477
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 15 '25
Buy
1.48
500,000
740,850
213,036,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 13 '24
Buy
1.59
125,000
199,375
212,536,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 11 '24
Buy
1.56
500,000
781,050
212,411,477
diagnostics_research DGX
$179.33
price down icon 0.17%
diagnostics_research WAT
$357.04
price up icon 2.29%
diagnostics_research LH
$264.26
price up icon 0.67%
$160.72
price down icon 4.87%
diagnostics_research MTD
$1,205.29
price up icon 2.60%
diagnostics_research IQV
$162.61
price up icon 3.19%
Kapitalisierung:     |  Volumen (24h):